Research Papers:

Leukocyte telomere length throughout the continuum of colorectal carcinogenesis

Cornelia Zöchmeister, Stefanie Brezina, Philipp Hofer, Andreas Baierl, Michael M. Bergmann, Thomas Bachleitner-Hofmann, Judith Karner-Hanusch, Anton Stift, Armin Gerger, Gernot Leeb, Karl Mach, Sivaramakrishna Rachakonda, Rajiv Kumar and Andrea Gsur _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:13582-13592. https://doi.org/10.18632/oncotarget.24431

Metrics: PDF 1699 views  |   HTML 2597 views  |   ?  


Cornelia Zöchmeister1,*, Stefanie Brezina1,*, Philipp Hofer1, Andreas Baierl2, Michael M. Bergmann3, Thomas Bachleitner-Hofmann3, Judith Karner-Hanusch3, Anton Stift3, Armin Gerger4, Gernot Leeb5, Karl Mach5, Sivaramakrishna Rachakonda6, Rajiv Kumar6 and Andrea Gsur1

1Medical University Vienna, Department of Medicine I, Institute of Cancer Research, Vienna, Austria

2University of Vienna, Department of Statistics and Operations Research, Vienna, Austria

3Medical University Vienna, Department of Surgery, Vienna, Austria

4Medical University of Graz, Division of Oncology, Department of Internal Medicine, Graz, Austria

5Hospital Oberpullendorf, Burgenland, Austria

6German Cancer Research Center, Division of Molecular Genetic Epidemiology, Heidelberg, Germany

*These authors have contributed equally to this work

Correspondence to:

Andrea Gsur, email: [email protected]

Keywords: telomere length; colorectal cancer; adenoma; cancer epidemiology

Received: September 08, 2017     Accepted: January 31, 2018     Published: February 07, 2018


Considering the high prevalence of colorectal cancer (CRC) and relatively high mortality there is strong interest in identification of clinically relevant biomarkers. Telomere shortening is supposed to contribute to genomic instability and crucially involved in process of carcinogenesis. Peripheral blood leukocyte (PBL) telomere length was previously investigated in several studies as potential biomarker for CRC but with controversial results. This prompted us to investigate relative PBL telomere length in association with different histological findings throughout the continuum of colorectal carcinogenesis in order to reflect the whole spectrum of putative CRC development in a large study involving 2011 individuals. The study based on the Colorectal Cancer Study of Austria (CORSA), including 384 CRC cases as well as age- and gender-matched 544 high-risk adenomas, 537 low-risk adenoma patients and 546 colonoscopy-negative controls. Relative expression of telomeric repeats and the single copy reference gene, albumin (T/S ratio) was determined using monochrome multiplex quantitative PCR (MMQPCR). Telomeres were found to be significantly longer in CRC patients compared to control subjects (P = 3.61x10-6). Yet, no significant differences in telomere length could be detected for high-risk (P = 0.05956) and low-risk colorectal adenoma patients (P = 0.05224). In addition, results presented in this manuscript highlight the impact of various epidemiological factors on PBL telomere length and its involvement in CRC. However, further large studies also including colorectal adenomas are necessary to confirm these results.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24431